Bristol-Myers Squibb

Bristol-Myers Squibb Overview

Founded 1887
Founded
Status Public
Employees 30,000
Employees
Stock Symbol BMY
Stock Symbol
Investments 55
Share Price $59.72 (As of Friday Closing)

Bristol-Myers Squibb General Information

Description

Bristol-Myers Squibb discovers, develops, and markets drugs for various indications, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is leading in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Drug Delivery
Stock Exchange
NYS
Primary Office
  • 430 East 29th Street
  • 14th Floor
  • New York, NY 10016
  • United States

Bristol-Myers Squibb Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Bristol-Myers Squibb Stock Performance

(As of Tuesday closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$59.72 $59.81 $42.48 - $68.34 $135B 2.26B 17.7M $0.82

Bristol-Myers Squibb Financials Summary

In Thousands,
USD
TTM 31-Mar-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 158,354,707 143,062,835 85,428,692 101,748,957
Revenue 31,006,000 26,145,000 22,561,000 20,776,000
EBITDA 7,718,000 7,377,000 6,788,000 6,116,000
Net Income 954,000 3,439,000 4,920,000 1,007,000
Total Assets 129,285,000 129,944,000 34,986,000 33,551,000
Total Debt 47,530,000 47,538,000 7,349,000 7,962,000
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bristol-Myers Squibb Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bristol-Myers Squibb‘s full profile, request access.

Request a free trial

Bristol-Myers Squibb Competitors (53)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
Amgen Formerly PE-Backed Thousand Oaks, CA 00000 00.000 000000000000 00.000
000 00000 Corporation Indianapolis, IN 00000 000000 - 000
00000 & 00. Corporation Kenilworth, NJ 00000 00000000
00000 000000000000 Formerly VC-backed South San Francisco, CA 000 000.00 000000 - 000 000.00
000000 Formerly VC-backed Cambridge, MA 0000 000.00 00000000000 000.00

Bristol-Myers Squibb Executive Team (49)

Name Title Board Seat Contact Info
Giovanni Caforio MD Chief Executive Officer & Chairman
Nadim Ahmed Executive Vice President & President
Payal Roy President- Oncology / Immuno-Oncology
David Elkins Chief Financial Officer, Finance & Executive Vice President
Karen Santiago Chief Accounting Officer, Accounting & Controller, Finance

22 Former Executives

Bristol-Myers Squibb Board Members (12)

To view Bristol-Myers Squibb‘s full board member team, request access >>
Name Representing Role Since
0000 0000 Self Board Member 000 0000
000000 0000000 Self Board Member 000 0000
000000 000000 00 Self Board Member 000 0000
00000000 0000000 00 Bristol-Myers Squibb Chief Executive Officer & Chairman 000 0000
0000000 000000000 Self Board Member 000 0000

4 Former Board Members

Bristol-Myers Squibb Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Bristol-Myers Squibb‘s full profile, request access.

Request a free trial

Bristol-Myers Squibb Investments & Acquisitions (55)

To view Bristol-Myers Squibb‘s complete investment and acquisition history, request access >>
Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 00000000000 27-May-2020 000000000 0000 Drug Discovery 000000 000000 00.0
0000000000 26-May-2020 00000 00000 00 000.00 Drug Discovery
0000000000 0000000 11-Mar-2020 00000 00000 00 000.00 Biotechnology
0000000 20-Nov-2019 000000000000000000 000.00 Biotechnology 00000000 0000000 00
Vedanta Biosciences 23-Sep-2019 Later Stage VC 000.00 Biotechnology

Ready to get started?

Request a free trial

Bristol-Myers Squibb Subsidiaries (7)

Company Name Industry Location Founded
IFM Therapeutics Drug Discovery Boston, MA 2015
0000000 Drug Discovery Copenhagen North, Denmark 0000
0000000 Biotechnology Summit, NJ 0000
0000000-00000 0000 Foundation New York, NY 0000
000000000000 Drug Discovery Seattle, WA 0000

Bristol-Myers Squibb Exits (17)

Company Name Exit Date Exit Type Exit Size Status Buyers
000 000 19-Jul-2018 00000 00000 00 000.00 Completed
  • 3 buyers
00000 0000000000 ( 21-Dec-2017 00000 00000 00 0000 Completed
  • 6 buyers
000000-0000000 000 22-Aug-2016 00 000000000000000 0000 Completed
  • 4 buyers
000000-0000000 000 01-Jan-2014 00000 0000000 Completed
  • 2 buyers
CytomX Therapeutics 31-Jul-2012 Early Stage VC 0000 Completed
  • 5 buyers